Back
Altimmune, Inc. Stock Predictions
Washington Wants Your Money. Here's How to Opt Out.
Learn how to become your own bank. Watch the free training.
Sell
16
ALT
Altimmune, Inc.
Last Price:
$3.52
Seasonality Move:
2.15%
7 Day Trial
ALL ACCESS PASS
$
7
Where Smart Money Buys Crypto (Hint: Not Coinbase)
Access Native Markets before the next 100x asset goes mainstream. Watch free training.Altimmune, Inc. Stock Forecast
-
Is Altimmune, Inc. Stock Undervalued?The current Altimmune, Inc. [ALT] share price is $3.61. The Score for ALT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
ALT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Altimmune, Inc. Stock Go Up Next Year?
Data Unavailable
Altimmune, Inc. Stock Rating
Data Unavailable
Altimmune, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com
52-Week Data
52-Week High:
7.83
52-Week Low:
2.90
Prediction Charts
Market Cap:
366.2M
Price in USD:
3.61
Volume:
4.3M
Beta:
1.16
Technical Analysis
SMA50:
4.47
SMA100:
4.12
SMA200:
4.59
52-Wk Change:
-50.63%
Stock Predictions
-
Is Altimmune, Inc. stock public?Yes, Altimmune, Inc. is a publicly traded company.
-
What is the Altimmune, Inc. stock quote today?The Altimmune, Inc. stock price is 3.61 USD today.
-
How to buy Altimmune, Inc. stock online?You can buy Altimmune, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-11 | 5.40 | 5.34 | 5.63 | 5.31 |
| Dec-12 | 5.40 | 5.27 | 6.03 | 5.25 |
| Dec-15 | 5.29 | 5.27 | 5.50 | 5.17 |
| Dec-16 | 5.22 | 5.02 | 5.28 | 4.92 |
| Dec-17 | 5.03 | 5.09 | 5.37 | 5.02 |
| Dec-18 | 5.23 | 5.03 | 5.28 | 5.02 |
| Dec-19 | 4.58 | 3.90 | 4.59 | 3.83 |
| Dec-22 | 3.96 | 4.14 | 4.45 | 3.95 |
| Dec-23 | 4.10 | 4.00 | 4.16 | 3.98 |
| Dec-24 | 4.05 | 3.98 | 4.11 | 3.97 |
| Dec-26 | 3.97 | 3.86 | 3.99 | 3.84 |
| Dec-29 | 3.84 | 3.68 | 3.84 | 3.65 |
| Dec-30 | 3.68 | 3.61 | 3.72 | 3.60 |
| Dec-31 | 3.60 | 3.61 | 3.63 | 3.52 |
Altimmune, Inc. Earnings
Data Unavailable
Altimmune, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and an increase next year of $0.16 per share.
* Altimmune, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.